Results 161 to 170 of about 50,819 (268)

Familial Myasthenia Gravis

, 1982
Unilateral Ptosis; External OphthalmoplegiaOcular Myasthenia Gravis: Past, Present and Future: https://collections.lib.utah.edu/details?id=2174219Droopy eyelidsIn 1999 Dr. A. G.
Shirley H. Wray, MD, PhD, FRCP
core  

Cardiovascular Immune‐Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review and Meta‐Summary of Case Reports

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Reports of immune checkpoint inhibitor (ICI) therapy‐associated immune‐related adverse events (irAEs) exhibit considerable heterogeneity, particularly when comparing data from clinical trials and real‐world observational studies. Methods We conducted a systematic review of real‐world observational studies (case reports and series ...
Shea‐Lee Godin, Tyler Kingma, Ashwin Pillai, Obada Kholoki, Agnes S. Kim   +4 more
wiley   +1 more source

Myasthenia Gravis (video)

, 2017
Myasthenia gravis is a disorder of neuromuscular transmission resulting from binding of autoantibodies to various components of the neuromuscular junction.
Matthew J. Thurtell
core  

Pragmatic Phenotype–Electrophysiology–Genomics Integration in Pediatric Congenital Myasthenic Syndromes: Insights From 36 Patients in a Single‐Center Study in China

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
In 36 Chinese pediatric CMS patients, integrated phenotype, RNS, and genomic assessment revealed marked genetic heterogeneity across 17 CMS‐associated genes and frequent VUS‐related uncertainty. Genotype‐informed therapy improved MG‐ADL scores, while CHAT‐CMS identified a high‐risk subgroup for early respiratory failure and mortality.
Liya Cui, Kaiyue Ma, Xiaona Fu, Lin Ge, Bingbing Jia, Wenna Ma, Lei Yang, Zhimei Liu, Junlan Lv, Wenmiao Xu, Lijuan Wang, Guangyuan Zhao, Jiuwei Li, Jie Wu, Quan Wang, Changhong Ding, Xiaotun Ren, Xinming Shen, Hui Xiong   +18 more
wiley   +1 more source

Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics

Frontiers in Immunology
Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Peng Liu, Peng Liu, Peng Liu, Peng Liu, Guoyan Qi, Guoyan Qi, Guoyan Qi, Guoyan Qi   +11 more
doaj   +1 more source

Exosomes in Myasthenia Gravis-Review. [PDF]

Cells
Ejdys K, Mycko MP.
europepmc   +1 more source

Myasthenia Gravis: Recent Developments

, 2005
To: 1. Describe the potential mechanisms for preferential involvement of ocular muscles by myasthenia gravis; 2. Discuss risks and benefits of corticosteroid use for treatment of ocular myasthenia; 3. Appropriately use edrophonium, serum autoantibody and
Henry J. Kaminski, MD
core  

The Relationship Between Lichen Planus and Thyroid Disorders in an Iranian Population: A Case‐Control Study

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Previous research investigated the connection between lichen planus (LP) and thyroid disorders due to their autoimmune characteristics; however, the correlation remains unclear. This study investigates the relationship between thyroid disorders and specific subtypes of LP, particularly cutaneous lichen planus (CLP) and ...
Safoura Shakoei, Helya Bolouki Azari, Arman Soleimany, Adnan Mastalizadeh, Maryam Daneshpazhooh   +4 more
wiley   +1 more source

Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn

The Journal of Clinical Pharmacology, Volume 66, Issue 9, September 2026.
Abstract Nipocalimab, a neonatal Fc receptor (FcRn) blocker, is under evaluation for severe hemolytic disease of the fetus and newborn (HDFN). In the Phase 2 UNITY trial, weekly intravenous antenatal treatment with nipocalimab at dose regimens of 30 and 45 mg/kg prevented fetal anemia requiring intrauterine transfusion (IUT) in 54% of high‐risk ...
Jie Zhou, Yuan Xiong, Edwin Lam, Leona E. Ling, Shumyla Saeed‐Khawaja, Yosuke Komatsu, An Vermeulen, Mahesh N. Samtani, Jocelyn H. Leu   +8 more
wiley   +1 more source

Women and Myasthenia Gravis. [PDF]

Ann Indian Acad Neurol
Menon D, Vengalil S, Nashi S, Nalini A.
europepmc   +1 more source